Omicron Boosters Available From Next Month
"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1677282_1_20221126100138.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.htm', 'DCS.dcsqry', '' ); } } }); }); });
2022-11-26 HKT 09:22
Booster shots that protect against both the highly-infectious Omicron variant, and the original Covid strain, will be available to the public from next month.
The government made the announcement after around 770,000 doses of the so-called bivalent shots arrived here on Friday. But the Secretary for the Civil Service, Ingrid Yeung, who is in charge of the Covid vaccination programme, said these BioNTech bivalent jabs would only be available as a fourth dose alternative.
"The bivalent vaccine is only for those who are having their fourth dose," she said. "Those who are having their first to third dose, they will not have this choice of the bivalent vaccine or the one that we have already been using."
Currently, the public can choose between the original BioNTech mRNA vaccine, marketed here as Comirnaty, and the Sinovac deactivated virus jab.
The government recommends two groups receive a fourth dose, namely people over 50 and anyone with a weak immune system. People under 50 can also get a fourth Covid shot on a voluntary basis.
The Government has procured a total of 1.9 million doses of the BioNTech bivalent mRNA vaccine. The remaining doses are expected by the end of the year.
mRNA vaccines are new type of vaccine that trigger the body to produce a protein which leads to an immune response.
XTransfer Partners With Bank SinoPac HK To Expand Cross-Border Payment Services
XTransfer has entered into a collaboration with Bank SinoPac, through its Hong Kong Branch, to expand international ope... Read more
Standard Chartered To Launch Bitcoin And Ethereum Custody Services By 2026
Standard Chartered Bank (Hong Kong) participated in Hong Kong Fintech Week 2025 (HKFTW25) as a strategic partner, annou... Read more
HashKey And Kraken Form Partnership On Institutional Tokenised Assets
HashKey and Kraken have announced a strategic partnership to promote institutional adoption of tokenised assets. The co... Read more
Reap Expands Global HQ With New Office In Hong Kong
Reap, a global fintech company providing stablecoin-enabled financial infrastructure, has expanded its global headquart... Read more
HeyMax Debuts In Hong Kong, Partnering With Cathay To Drive Regional Growth
Loyalty and travel rewards platform HeyMax has made its first international launch in Hong Kong, partnering with Cath... Read more